
Intellia Therapeutics (NTLA) Market Capitalization Overview
Market Cap: $1.50B as of Oct 28, 2025
$1.50B
Past Month-$252.27M (14.41%)
As of Oct 28, 2025, Intellia Therapeutics (NTLA) has a market capitalization of $1.50B. Over the past 30 days, its market cap has increased by 64.56%, while in the last 12 months, it has increased by 26.19%.
Market capitalization represents the total value of Intellia Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Intellia Therapeutics (NTLA) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Intellia Therapeutics (NTLA) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Intellia Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Intellia Therapeutics (NTLA) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Intellia Therapeutics (NTLA) helps investors assess the company's size and compare it with competitors for better investment decisions.
Intellia Therapeutics (NTLA) Market Cap & Key Trends
See Intellia Therapeutics’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Intellia Therapeutics (NTLA)
Order type
Buy in
Order amount
Est. shares
0 shares
Intellia Therapeutics (NTLA) Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Oct 1, 2025 | $2.02B | +64.56% |
| Sep 2, 2025 | $1.23B | +2.82% |
| Aug 1, 2025 | $1.20B | +16.30% |
| Jul 1, 2025 | $1.03B | +37.99% |
| Jun 2, 2025 | $741.66M | -17.08% |
| May 1, 2025 | $894.39M | +29.83% |
| Apr 1, 2025 | $688.91M | -29.58% |
| Mar 3, 2025 | $978.24M | +0.68% |
| Feb 3, 2025 | $971.64M | -21.93% |
| Jan 2, 2025 | $1.25B | -22.31% |
Intellia Therapeutics (NTLA) End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2025 | $1.50B | +26.19% |
| 2024 | $1.19B | -56.51% |
| 2023 | $2.74B | -8.18% |
| 2022 | $2.98B | -66.20% |
| 2021 | $8.80B | +173.78% |
| 2020 | $3.22B | — |
FAQs About Intellia Therapeutics (NTLA) Market Cap
As of Oct 28, 2025, the market capitalization of Intellia Therapeutics (NTLA) is $1.50B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Intellia Therapeutics’s market capitalization has decreased by -14.41%, changing from $1.76B to $1.50B as of Oct 28, 2025.
In the last 3 months, Intellia Therapeutics’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, Intellia Therapeutics’s market capitalization decreased from $2.74B in January to $1.19B in December, reflecting a -56.51% change.
In the past five years, Intellia Therapeutics (NTLA) has had a compound annual growth rate (CAGR) of -18.06% in market capitalization. This means its market cap has shrunk at an average rate of -18.06% per year.